Showing results (291-300 of 372) with videos related to
Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapyK Antman, L Ayash, A Elias, et al.International Journal of Oncology|April 11, 2009
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogsRebecca G Bagley, Stephanie Roth, Leslie S Kurtzberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-betaVictoria C Liu, Larry Y Wong, Thomas Jang, et al.SLAS Discovery : Advancing Life Sciences R & D|March 14, 2017
3D Models of the NCI60 Cell Lines for Screening Oncology CompoundsMike Selby, Rene Delosh, Julie Laudeman, et al.Seminars in Oncology|February 1, 1990
High-dose thiotepa alone and in combination regimens with bone marrow supportK Antman, J P Eder, A Elias, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2011
Placental growth factor upregulation is a host response to antiangiogenic therapyRebecca G Bagley, Yi Ren, William Weber, et al.SLAS Discovery : Advancing Life Sciences R & D|April 10, 2025
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroidsNathan P Coussens, Thomas S Dexheimer, Thomas Silvers, et al.SLAS Discovery : Advancing Life Sciences R & D|October 23, 2025
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroidsThomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.Molecular and Cellular Biochemistry|June 1, 1990
Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinumS D Bernal, J A Speak, K Boeheim, et al.International Journal of Cancer|January 21, 1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)B A Teicher, S A Holden, T S Herman, et al.Pageof 38